J1710 — Injection, hydrocortisone sodium phosphate, up to 50 mg
J1710 is a HCPCS Level II code for injection, hydrocortisone sodium phosphate, up to 50 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1710 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1710
- Long descriptor
- Injection, hydrocortisone sodium phosphate, up to 50 mg
- Short descriptor
- Hydrocortisone sodium ph inj
- Added
- January 1, 1982
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1710
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1710 is not quite right, the correct code is very often within a few positions of it.
- J1644Injection, heparin sodium, per 1000 units
- J1645Injection, dalteparin sodium, per 2500 iu
- J1650Injection, enoxaparin sodium, 10 mg
- J1652Injection, fondaparinux sodium, 0.5 mg
- J1655Injection, tinzaparin sodium, 1000 iuterminated
- J1670Injection, tetanus immune globulin, human, up to 250 units
- J1675Injection, histrelin acetate, 10 micrograms
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1720Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725Injection, hydroxyprogesterone caproate, 1 mgterminated
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730Injection, diazoxide, up to 300 mg
- J1736Injection, meloxicam (delova), 1 mg
- J1737Injection, meloxicam (azurity), 1 mg
- J1738Injection, meloxicam, 1 mg
Questions about J1710
What is HCPCS code J1710?
J1710 is a HCPCS Level II code for injection, hydrocortisone sodium phosphate, up to 50 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1710?
The CMS HCPCS file marks J1710 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J1710 still valid?
No. J1710 was terminated on December 31, 2025 and should not be used on new claims.